Mortality Rates in Individuals with Schizophrenia: Evaluation of Contributing Factors and Intervention Strategies

Schizophrenia is a serious mental illness with a significantly higher mortality rate than the general population. People with schizophrenia face a greater risk of early death due to comorbidities, lifestyle choices, and side effects from antipsychotic medications. This research explores the factors contributing to this increased risk, emphasizing the impact of cardiovascular disease, diabetes, and respiratory conditions, all worsened by unhealthy lifestyles such as smoking, poor dietary habits, and lack of exercies. The study also examines the role of antipsychotics, particularly second-generation antipsychotics, in increasing metabolic and cardiovascular risk. In addition, socioeconomic status (SES) is recognised as a key social determinant, as people with lower SES experience greater health disparities and less access to healthcare. This study evaluated existing intervention strategies, such as integrated care models and lifestyle interventions, and assessed their effectiveness in reducing mortality risk. By addressing these factors, this study aims to inform healthcare policy and improve care and life expectancy for individuals with schizophrenia.